Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Intrathecal Fentanyl Induced Pruritus
NCT06243120Phase 1Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in pruritus (2 arms), sponsored by Ain Shams University. Primary endpoint: Regression of initial VAS score. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT06243120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243120.